OPTHERION
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
OPTHERION
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.optherion.com
Total Employee:
11+
Status:
Active
Contact:
2034920287
Total Funding:
42 M USD
Technology used in webpage:
Viewport Meta Font Awesome Amazon BootstrapCDN Amazon Virginia Region Apache 2.2 NameBright StatCounter OpenSSL 0.9.8 Mod_ssl 2.2.22
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Current Advisors List
Current Employees Featured
Founder
Investors List
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series A - Optherion
GE Healthcare
GE Healthcare investment in Series A - Optherion
Domain Associates
Domain Associates investment in Series A - Optherion
Quaker BioVentures
Quaker BioVentures investment in Series A - Optherion
Pappas Ventures
Pappas Ventures investment in Series A - Optherion
Official Site Inspections
http://www.optherion.com
- Host name: 104.21.86.219
- IP address: 104.21.86.219
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
